George Clinical Expands Asia-Pacific Footprint with New Location in the Philippines

SYDNEY, May 29, 2019 /PRNewswire/ — George Clinical, a global scientifically-backed clinical research organization (CRO), has again expanded its extensive Asia-Pacific footprint through the opening of a new office in the Philippines. The office is based in the capital city, Manila and compliments the organization’s growing list of global locations.

The opening of this office formalizes a long-standing strategic focus on the country and the region, by increasing investigator networks and collaborative solutions to enhance study quality, study performance and shorten start timelines. The Philippines is a strong performer in the Asian clinical trial landscape, not only due to a large cohort of treatment naïve patients, but generally good treatment adherence, and a high level of English literacy.  

“George Clinical is honoured to formalize our presence in the Philippines,” Evon Hui, Head of Business Operations, East Asia said. “We have a long standing strategic focus on building the clinical trial infrastructure in the Philippines. Through the development of this entity, George Clinical looks forward to working with sponsors to make the most of the benefits that running a clinical trial in the Philippines will provide.”

Historically, The Philippines has a particularly strong track record in the conduct of infectious diseases, oncology, metabolic disorders, respiratory and cardiovascular trials. George Clinical has an extensive track record in chronic disease trials that correlates directly with the most prevalent indications in the country.

About George Clinical

George Clinical is a leading global clinical research organization founded in Asia-Pacific driven by scientific expertise and operational excellence. With 20 years of experience and more than 300 staff managing 38 geographical locations throughout the USA, Asia-Pacific region and Europe, George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration and post-marketing trials.    

Contact:          mreabold@georgeclinical.com
Website:          https://www.georgeclinical.com
LinkedIn:         https://www.linkedin.com/company/george-clinical-pty-ltd
Twitter:            https://twitter.com/george_clinical
Facebook:       https://www.facebook.com/georgeclinical

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/george-clinical-expands-asia-pacific-footprint-with-new-location-in-the-philippines-300858071.html

SOURCE George Clinical

Staff

Recent Posts

Sona Nanotech Updates on Dalhousie Efficacy Study and New NCL Results

Halifax, Nova Scotia--(Newsfile Corp. - March 25, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB:…

31 mins ago

GE HealthCare Announces the FDA Clearance of nCommand Lite by IONIC Health

GE HealthCare to exclusively distribute nCommand Lite by IONIC Health for multi-vendor, multi-modality remote operations…

1 hour ago

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for…

1 hour ago

Politan Nominates Two Independent Candidates for Masimo Board

Supports Strategic Review of Consumer Business, But Has Serious Concerns Given Masimo’s Broken Governance and…

1 hour ago

Akanda Corp. Announces Pricing of Underwritten Public Offering

London, United Kingdom--(Newsfile Corp. - March 25, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or…

1 hour ago